Accumulating evidence has shown that FPR2 is involved in the host’s defense against bacterial infection and inflammation in liver diseases, such as nonalcoholic fatty liver disease, liver fibrosis, and liver cancer, suggesting the pathophysiological relevance of FPR2 to the liver. Here, FPR2 is linked to Hepatic fibrosis.